For Pfizer Chief, The First Order Of Business Is Research
This article was originally published in The Pink Sheet Daily
Executive Summary
In Read's first presentation to investors, the new chief executive laid out plans to reorganize research as part of a strategy to improve productivity and cut spending by $1.5 billion in 2012.